MEZLOCILLIN SODIUM MONOHYDRATE pharmaceutical API fine chemical suppliers

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
BioCrick	⤷ Start Trial	BCC5634	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: February 19, 2026

This report identifies key manufacturers and suppliers of bulk Mezlocillin Sodium Monohydrate active pharmaceutical ingredient (API), analyzes current market trends impacting API procurement, and outlines regulatory considerations for sourcing this critical antibiotic. The focus is on established suppliers with documented Good Manufacturing Practices (GMP) compliance and relevant regulatory filings.

What is Mezlocillin Sodium Monohydrate?

Mezlocillin Sodium Monohydrate is a broad-spectrum, semi-synthetic penicillin antibiotic. It belongs to the ureidopenicillin class and is characterized by its extended activity against Gram-negative bacteria, including Pseudomonas aeruginosa, and its stability against beta-lactamase enzymes. It is primarily administered intravenously for the treatment of serious bacterial infections. The monohydrate form refers to the crystalline structure containing one molecule of water per molecule of Mezlocillin Sodium.

Global API Manufacturing Landscape

The global production of bulk APIs, including Mezlocillin Sodium Monohydrate, is concentrated in specific regions due to factors such as manufacturing expertise, cost efficiencies, and established supply chains. Asia, particularly China and India, remains a dominant force in API manufacturing. Europe also maintains a significant presence, often focusing on higher-value, niche, or highly regulated APIs.

Key Manufacturing Regions and Their Characteristics

China: Dominant global supplier for many APIs due to large-scale production capacity, cost competitiveness, and a comprehensive chemical industry infrastructure. Many Chinese manufacturers have invested significantly in upgrading GMP standards to meet international regulatory requirements.
India: A leading producer of generic APIs, known for its strong pharmaceutical research and development capabilities and a large pool of skilled labor. Indian manufacturers are heavily regulated by the US FDA and EMA.
Europe: Home to established pharmaceutical ingredient manufacturers in countries like Germany, Switzerland, and Italy. European producers often focus on complex APIs, specialized synthesis, and APIs requiring stringent quality control and regulatory compliance. They may offer advantages in supply chain reliability and adherence to the highest GMP standards.
United States: While the US is a major consumer of APIs, domestic bulk API manufacturing has seen a resurgence in recent years, particularly for critical medicines, driven by supply chain security concerns.

Identified Bulk API Suppliers for Mezlocillin Sodium Monohydrate

The following suppliers have been identified as having the capability and established presence in the market to provide bulk Mezlocillin Sodium Monohydrate API. Verification of current product availability, GMP certification status, and regulatory filings (e.g., Drug Master Files, CEPs) is critical for procurement.

Supplier Name	Country of Origin	Key Product Offerings	Notes
Sandoz	Switzerland	Bulk antibiotics, including penicillins	Global presence, strong regulatory track record. Part of Novartis.
Teva Pharmaceutical Industries Ltd.	Israel	Wide range of generic APIs, including cephalosporins and penicillins	Large-scale manufacturer with extensive global reach and regulatory experience.
Novartis AG	Switzerland	Broad portfolio of APIs, often through subsidiaries	May supply through specialized divisions or acquired entities.
Sanofi	France	Antibiotic APIs, often with a focus on established therapies	Significant player in antibiotics. Procurement may involve specific business units.
Aurobindo Pharma Ltd.	India	Large portfolio of APIs, including beta-lactams	Known for high-volume production and competitive pricing. Strong regulatory adherence.
Dr. Reddy's Laboratories	India	Diverse API portfolio, including anti-infectives	Well-established API supplier with significant R&D and manufacturing capabilities.
Lupin Ltd.	India	Extensive range of APIs, particularly in anti-infectives	Focus on penicillin and cephalosporin derivatives.
CordenPharma	Germany	Contract development and manufacturing organization (CDMO)	May offer custom synthesis or supply through dedicated manufacturing campaigns for specific clients.
Shanghai Pharmaceutical Holding Co., Ltd.	China	Diverse API production, including antibiotics	Significant API producer in China with growing international regulatory compliance.
Zhejiang Huahai Pharmaceutical Co., Ltd.	China	Broad API range, strong in cardiovascular and CNS APIs	Increasing focus on antibiotic APIs and international market access.

Market Trends Impacting API Procurement

The procurement of bulk APIs is subject to several dynamic market forces. Understanding these trends is essential for strategic sourcing and risk mitigation.

Supply Chain Resilience and Geopolitical Factors

The COVID-19 pandemic highlighted vulnerabilities in global pharmaceutical supply chains. Consequently, there is increased emphasis on:

Diversification of Suppliers: Reducing reliance on single geographic regions or manufacturers.
Nearshoring/Reshoring: While complex for established APIs, there is growing interest in bringing some API manufacturing closer to end markets.
Inventory Management: Maintaining strategic reserves of critical APIs to buffer against disruptions.
Geopolitical Stability: Conflicts and trade disputes can impact raw material availability and transportation costs.

Regulatory Scrutiny and Compliance

Regulatory bodies worldwide (FDA, EMA, PMDA, etc.) are intensifying their oversight of API manufacturing. This includes:

Increased Inspections: More frequent and rigorous GMP inspections of manufacturing facilities.
Data Integrity: Strict requirements for the accuracy, completeness, and reliability of manufacturing data.
Impurity Profiling: Enhanced focus on identifying and controlling genotoxic and other critical impurities.
Drug Master File (DMF) / Active Substance Master File (ASMF) Requirements: Updated and robust filings are mandatory for market approval.

Cost Pressures and Economic Factors

While cost remains a significant driver, it is increasingly balanced against quality and reliability.

Raw Material Volatility: Fluctuations in the cost of chemical precursors and solvents impact API pricing.
Energy Costs: Rising energy prices affect manufacturing overheads.
Labor Costs: Wage inflation in key manufacturing regions influences pricing.
Environmental Regulations: Stricter environmental standards can lead to increased manufacturing costs for compliance.

Technological Advancements in Manufacturing

Continuous Manufacturing: Adoption of continuous processing technologies aims to improve efficiency, reduce waste, and enhance product quality control.
Process Analytical Technology (PAT): Real-time monitoring and control of manufacturing processes to ensure consistent quality.
Biotechnology: While Mezlocillin Sodium Monohydrate is produced synthetically, advancements in biocatalysis and fermentation technologies are impacting other API classes and could influence future production methods or precursor sourcing.

Regulatory Considerations for Sourcing

Sourcing bulk Mezlocillin Sodium Monohydrate requires meticulous attention to regulatory compliance to ensure the safety, efficacy, and quality of the final drug product.

Good Manufacturing Practices (GMP)

Compliance with current GMP standards is non-negotiable. This includes:

ICH Q7 Guideline: "Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients."
Facility Audits: Conducting thorough on-site audits of potential suppliers' manufacturing facilities to verify GMP adherence, quality control systems, and documentation practices.
Quality Agreements: Establishing comprehensive quality agreements with suppliers outlining responsibilities, change control procedures, and dispute resolution mechanisms.

Regulatory Filings and Documentation

Drug Master Files (DMFs) / Active Substance Master Files (ASMFs): Suppliers must possess approved or pending DMFs (US) or ASMFs (EU and other regions). These confidential documents provide regulatory agencies with detailed information about the manufacturing process, quality control, and stability of the API.
Certificates of Suitability (CEP): Issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM), a CEP demonstrates that the API complies with the requirements of the European Pharmacopoeia. This simplifies the regulatory process for products intended for the European market.
Pharmacopoeial Compliance: The API must meet the specifications outlined in relevant pharmacopoeias, such as the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Japanese Pharmacopoeia (JP).
Traceability: Ensuring full traceability of raw materials, intermediates, and finished API batches.

Supplier Qualification Process

A robust supplier qualification program is essential:

Initial Screening: Review of supplier credentials, regulatory history, and capacity.
Document Review: Evaluation of DMFs/ASMFs, site master files, and quality certifications.
Audits: On-site GMP audits by the purchasing company's quality assurance team.
Sample Testing: Independent testing of API samples to confirm quality and purity.
Ongoing Monitoring: Regular performance reviews and periodic re-audits.

Pricing and Availability Dynamics

The price of bulk Mezlocillin Sodium Monohydrate is influenced by several factors:

Manufacturing Volume: Larger production runs generally lead to lower per-unit costs.
Raw Material Costs: Fluctuations in the price of precursors directly impact API pricing.
Regulatory Compliance Costs: Investments in GMP upgrades, quality systems, and regulatory submissions are factored into pricing.
Market Demand: High demand relative to supply can drive prices up. Conversely, oversupply can lead to price erosion.
Supplier Location: Manufacturing location, considering labor, energy, and logistical costs, plays a role.
Contractual Terms: Long-term supply agreements with guaranteed volumes can offer more stable pricing.

Availability can be subject to:

Production Capacity: Suppliers' existing production schedules and their capacity to meet demand.
Raw Material Lead Times: Delays in obtaining essential precursors can impact production timelines.
Logistics and Shipping: Global shipping challenges, customs delays, and transportation costs can affect timely delivery.
Regulatory Approvals: Delays in obtaining or maintaining regulatory approvals can impact a supplier's ability to sell into certain markets.

It is advisable to obtain quotes from multiple qualified suppliers and to negotiate pricing based on volume commitments and long-term partnership potential. Market intelligence regarding upcoming demand and potential supply disruptions is crucial for proactive procurement.

Key Takeaways

Supplier Concentration: Major bulk API suppliers for Mezlocillin Sodium Monohydrate are primarily located in Asia (China, India) and Europe, with a few significant players in Israel.
Regulatory Imperative: Stringent GMP compliance, robust regulatory filings (DMF/ASMF), and adherence to pharmacopoeial standards are paramount for any qualified supplier.
Supply Chain Risks: Geopolitical instability, raw material volatility, and increased regulatory scrutiny are key factors impacting sourcing strategies.
Supplier Qualification: A rigorous and ongoing supplier qualification process, including on-site audits, is essential.
Pricing Influences: API costs are shaped by manufacturing volume, raw material prices, regulatory compliance investments, and market demand.

Frequently Asked Questions

What is the typical lead time for ordering bulk Mezlocillin Sodium Monohydrate API from a qualified supplier?

Typical lead times can range from 8 to 16 weeks, depending on the supplier's production schedule, current inventory levels, and the complexity of the required regulatory documentation. Expedited orders may be possible but often incur higher costs.

How can I verify a supplier's GMP compliance for Mezlocillin Sodium Monohydrate?

Verification involves reviewing their official GMP certificates, conducting on-site audits by your quality assurance team, examining inspection reports from regulatory authorities (e.g., FDA Form 483s, EMA inspection outcomes), and reviewing the supplier's Quality Management System documentation.

Are there specific regional advantages or disadvantages when sourcing Mezlocillin Sodium Monohydrate API?

Sourcing from Asia often offers cost advantages due to large-scale production, but may require more rigorous due diligence on quality and regulatory compliance. European suppliers may offer higher inherent quality assurance and supply chain reliability, though often at a premium price.

What is the significance of a Drug Master File (DMF) or Active Substance Master File (ASMF) when evaluating a supplier?

A DMF/ASMF provides regulatory authorities with a comprehensive and confidential overview of the API's manufacturing process, controls, and stability. Its existence and acceptance by regulatory bodies are critical for the approval of the finished drug product that utilizes the API.

How do market fluctuations in raw material prices impact the cost of Mezlocillin Sodium Monohydrate API?

The cost of key chemical precursors and solvents used in the synthesis of Mezlocillin Sodium Monohydrate directly influences its final API price. Significant price volatility in these raw materials can lead to upward pressure on API costs.

Citations

[1] European Directorate for the Quality of Medicines & HealthCare (EDQM). (n.d.). Certificates of Suitability to the monographs of the European Pharmacopoeia. Retrieved from https://www.edqm.eu/en/certificates-suitability-monographs-european-pharmacopoeia

[2] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2009). ICH Harmonised Tripartite Guideline: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q7. Retrieved from https://www.ich.org/page/quality-guidelines

[3] U.S. Food and Drug Administration (FDA). (n.d.). Drug Master Files. Retrieved from https://www.fda.gov/drugs/ylmethylene-chloride-drug-master-files

Bulk Pharmaceutical API Sources for mezlocillin sodium monohydrate